Ann Arbor, MI — January 2025 — MH3D Inc., an emerging innovator in medical imaging technology, has launched the Alpha-SPECT Mini, a compact pre-clinical Single Photon Emission Computed Tomography (SPECT) system. Designed exclusively for pre-clinical research, the Alpha-SPECT Mini delivers exceptional imaging performance tailored to the demands of advanced studies. Leveraging advanced Cadmium Zinc Telluride (CZT) detector technology, this system sets a new standard in animal imaging.
The Alpha-SPECT Mini is engineered to provide efficiency and precision for pre-clinical applications. Its key capabilities include:
Unparalleled spatial resolution for detailed imaging of small biological structures.
Ultra-high Energy resolution, enhancing the accuracy and reliability of multi-isotope studies.
This system supports a range of research applications, including disease modeling, radiopharmaceutical development, and drug efficacy studies. Its compact design integrates seamlessly into pre-clinical labs with space or resource constraints, reducing operational overhead without compromising image quality.
MH3D has already partnered with institutions such as Johns Hopkins University and Alpha-9 Oncology to evaluate alpha-therapy efficacy using the Alpha-SPECT Mini. Preliminary studies have demonstrated its capability to deliver consistent, reproducible imaging results that exceed traditional scintillator-based systems in accuracy and resolution.
“The Alpha-SPECT Mini was engineered to address the specific challenges of pre-clinical imaging, particularly in facilities that require high-performance systems in compact form factors,” said Xiaopei Huang, CEO of MH3D. “Our focus was on developing a tool that not only meets but exceeds the imaging requirements for next-generation research.”
Product Highlights:
Compact Design: Small footprint optimized for labs with limited space.
Rapid Acquisition Time: Enables efficient data collection to support high-throughput research.
Solid-State Durability: CZT detectors enhance durability and ensure consistent performance over extended periods.
The Alpha-SPECT Mini is now available for purchase, with demonstrations offered upon request. MH3D invites researchers and institutions to explore the system’s capabilities and see firsthand how it advances pre-clinical imaging standards.
For technical specifications, research applications, or to schedule a demo, contact us via the contact form at www.mh3dinc.com
About MH3D Inc. MH3D Inc. is an Ann Arbor-based medical imaging company dedicated to advancing diagnostic technology through state-of-the-art clinical SPECT solutions. A spinout from the University of Michigan and the University of Illinois, MH3D is committed to improving patient care and setting new standards in nuclear medicine.
Comments